AGTC News and Press, Applied Genetic Technologies Corporation From 05/14/21

SAN DIEGO, May 14, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced preclinical proof-of-concept results for OTO-825 presented at the American Society of Gene &...

Applied Genetic Technologies (AGTC) announces that it has initiated plans to lease a build-to-suit 21K sq ft current Good Manufacturing Practices ((cGMP)) manufacturing and quality control facility.The expansion aims to help prepare for anticipated late-stage development of its X-Linked Retin...

- Company plans to lease 21,000 square foot build-to-suit cGMP manufacturing facility adjacent to its Florida facility - - Obtained additional $10 million in debt and maturity extension under an amended loan agreement with Hercules - GAINESVILLE, Fla. and CAMBRIDGE, Mass...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, today a...

Applied Genetic Technologies (AGTC) presents new data from two studies related to improvements in the manufacturing process for rAAV2tYF-GRK1-RPGRco, a gene therapy candidate for the treatment of X-linked retinitis pigmentosa ((XLRP)). Subretinal Rd9 Mouse Study to Compare RPGR Expression Pre...

-Improved process and validated expression assay support clinical phase product release for the Vista Phase 2/3 XLRP clinical trial- GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology co...

Stealth BioTherapeutics (MITO) +58% after showcases data for Elamipretide.Luokung Technology Corp. (LKCO) +22% on announcing favorable ruling granting preliminary injunction.Nemaura Medical (NMRD) +23% on 200K sugarBEAT sensors order.American Shared Hospital Services (AMS) +28%...

-Groups 5 and 6 had a 50% response rate among patients who met the inclusion criteria for the Skyline and Vista trials- -Best Corrected Visual Acuity (BCVA) data continue to provide supportive evidence of biological response at 12 months- -Data from a subset of Group 4 p...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, today a...

Announcing its Q1 2021 results, Editas Medicine (EDIT) said that the cash and equivalents as of March 31 have improved to $6.5M indicating ~41.3% growth from the 2020-year end, and along with interest, the liquidity could fund its operations and capex until at least 2023.Howeve...